Imagine a beautiful mushroom. Do you see a dome-shaped cap atop a slender stem? Visualize the cap’s color. Is it, perhaps, a deep red adorned with white dots?
If so, you have envisioned the most commonly portrayed mushroom in mainstream culture Amanita muscaria, commonly known as the fly agaric.
New research evidence suggests that meditation can modulate brain activity, specifically via the inhibitory neurotransmitter gamma-aminobutyric acid (GABA) [3-6]. Though this may perhaps not be surprising to devotees of the practice, in this article we will investigate the relationship between meditation and this important neurotransmitter in the brain and nervous system.
Yes indeed! They are PONs + psychoplastogens! Let us explain...
The use of classical psychedelic substances for therapeutic purposes has surged in recent years. Although in its infancy, research has also alluded to the potential benefits of "microdosing" psychedelics for health and wellness, namely by lowering depression, anxiety, and stress as well as enhancing cognitive performance .
In this article, we will explore an important neurotransmitter in the body and brain called acetylcholine (ACh). While also functioning as a classical neuromodulator, ACh is similar to norepinephrine, serotonin, and dopamine in that it cannot cross the blood-brain barrier.
In today’s article, we are going to cover the “fight or flight” (or “oh sh*t, there’s a bear!”) catecholamine and neurotransmitter known as norepinephrine (NE). As with gamma-aminobutyric acid (or GABA), serotonin, and dopamine, NE can’t cross the blood-brain barrier.
In today’s article, we are going to explore the well-known, indispensable, and now kind of infamous neurotransmitter, dopamine. As with GABA or gamma-aminobutyric acid and serotonin, dopamine can’t cross the blood-brain barrier.
Customers & Practitioners
Rehoboth Beach, DE
United States of America
Sign Up for Your Weekly Dose of Health Optimization